$67.6 Million is the total value of Opus Point Partners Management, LLC's 63 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 18.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IBB | ISHARES TRnasdaq biotech | $13,638,000 | -2.4% | 125,000 | 0.0% | 20.18% | +6.5% | |
| IBB | ISHARES TRcall | $9,274,000 | -2.4% | 85,000 | 0.0% | 13.72% | +6.5% | |
| LABU | Buy | DIREXION SHS ETF TRsp biotch bl new | $4,940,000 | -15.8% | 98,432 | +0.4% | 7.31% | -8.1% |
| MTD | METTLER TOLEDO INTERNATIONAL | $2,717,000 | +16.2% | 3,235 | 0.0% | 4.02% | +26.8% | |
| ILMN | Buy | ILLUMINA INC | $1,730,000 | +19.1% | 4,699 | +0.5% | 2.56% | +30.1% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $1,502,000 | +1.1% | 8,193 | +1.5% | 2.22% | +10.4% |
| BMY | BRISTOL MYERS SQUIBB CO | $1,497,000 | -4.9% | 33,000 | 0.0% | 2.22% | +3.8% | |
| ALXN | ALEXION PHARMACEUTICALS INC | $1,300,000 | -3.1% | 9,927 | 0.0% | 1.92% | +5.7% | |
| IONS | IONIS PHARMACEUTICALS INC | $1,293,000 | -20.8% | 20,124 | 0.0% | 1.91% | -13.6% | |
| PRQR | PROQR THRAPEUTICS N V | $1,260,000 | -34.4% | 138,461 | 0.0% | 1.86% | -28.4% | |
| SGEN | Buy | SEATTLE GENETICS INC | $1,239,000 | -5.1% | 17,901 | +0.4% | 1.83% | +3.6% |
| QGEN | QIAGEN NV | $1,170,000 | -0.3% | 28,858 | 0.0% | 1.73% | +8.8% | |
| QURE | UNIQURE NV | $1,111,000 | +31.0% | 14,215 | 0.0% | 1.64% | +43.1% | |
| EXAS | Buy | EXACT SCIENCES CORP | $1,007,000 | +90.7% | 8,534 | +40.1% | 1.49% | +108.1% |
| ONCE | SPARK THERAPEUTICS INC | $993,000 | -10.1% | 9,699 | 0.0% | 1.47% | -1.9% | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $969,000 | -22.4% | 13,351 | 0.0% | 1.43% | -15.2% | |
| INCY | INCYTE CORP | $902,000 | -1.2% | 10,613 | 0.0% | 1.34% | +7.9% | |
| IMMU | IMMUNOMEDICS INC | $868,000 | -27.8% | 62,575 | 0.0% | 1.28% | -21.2% | |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $813,000 | +109.5% | 5,353 | +64.6% | 1.20% | +128.7% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $805,000 | -0.4% | 9,400 | +3.3% | 1.19% | +8.8% |
| BLUE | BLUEBIRD BIO INC | $743,000 | -19.2% | 5,840 | 0.0% | 1.10% | -11.7% | |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $713,000 | -2.2% | 6,190 | 0.0% | 1.06% | +6.8% | |
| REGN | Buy | REGENERON PHARMACEUTICALS | $695,000 | -23.1% | 2,221 | +0.9% | 1.03% | -16.1% |
| INSM | INSMED INC | $690,000 | -11.9% | 26,936 | 0.0% | 1.02% | -3.8% | |
| BOLD | AUDENTES THERAPEUTICS INC | $656,000 | -3.1% | 17,339 | 0.0% | 0.97% | +5.9% | |
| BPMC | BLUEPRINT MEDICINES CORP | $640,000 | +17.9% | 6,780 | 0.0% | 0.95% | +28.7% | |
| GTHX | G1 THERAPEUTICS INC | $639,000 | +84.7% | 20,844 | 0.0% | 0.94% | +101.5% | |
| GWPH | GW PHARMACEUTICALS PLCads | $633,000 | +2.3% | 3,674 | 0.0% | 0.94% | +11.7% | |
| EPZM | EPIZYME INC | $632,000 | +1.3% | 50,378 | 0.0% | 0.94% | +10.5% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $622,000 | +31.8% | 13,214 | 0.0% | 0.92% | +43.8% | |
| ARNA | ARENA PHARMACEUTICALS INC | $573,000 | +30.8% | 9,770 | 0.0% | 0.85% | +42.8% | |
| CELG | Sell | CELGENE CORP | $520,000 | -35.2% | 5,625 | -33.9% | 0.77% | -29.3% |
| MGNX | MACROGENICS INC | $510,000 | -5.7% | 30,075 | 0.0% | 0.76% | +3.0% | |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $499,000 | -0.6% | 9,479 | 0.0% | 0.74% | +8.5% | |
| PCRX | PACIRA BIOSCIENCES | $489,000 | +14.3% | 11,250 | 0.0% | 0.72% | +24.8% | |
| BHVN | BIOHAVEN PHARMACTL HLDG CO L | $475,000 | -15.0% | 10,852 | 0.0% | 0.70% | -7.3% | |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $467,000 | -27.5% | 5,872 | +2.0% | 0.69% | -20.8% |
| NTLA | INTELLIA THERAPEUTICS INC | $466,000 | -4.3% | 28,490 | 0.0% | 0.69% | +4.4% | |
| ZGNX | ZOGENIX INC | $465,000 | -13.1% | 9,725 | 0.0% | 0.69% | -5.1% | |
| FOLD | AMICUS THERAPEUTICS INC | $458,000 | -8.4% | 36,731 | 0.0% | 0.68% | 0.0% | |
| NKTR | Buy | NEKTAR THERAPEUTICS | $445,000 | +28.6% | 12,503 | +21.3% | 0.66% | +40.3% |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $420,000 | -2.8% | 18,631 | 0.0% | 0.62% | +6.2% | |
| VKTX | VIKING THERAPEUTICS INC | $402,000 | -16.6% | 48,485 | 0.0% | 0.60% | -8.9% | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $374,000 | -16.3% | 3,570 | 0.0% | 0.55% | -8.7% | |
| FBIO | FORTRESS BIOTECH INC | $351,000 | -15.8% | 234,030 | 0.0% | 0.52% | -8.1% | |
| ANAB | ANAPTYSBIO INC | $345,000 | -22.8% | 6,116 | 0.0% | 0.51% | -15.8% | |
| CKPT | CHECKPOINT THERAPEUTICS INC | $342,000 | +6.2% | 112,760 | 0.0% | 0.51% | +16.1% | |
| AMRN | AMARIN CORP PLCspons adr new | $323,000 | -6.4% | 16,641 | 0.0% | 0.48% | +2.1% | |
| TECH | BIO TECHNE CORP | $323,000 | +4.9% | 1,551 | 0.0% | 0.48% | +14.6% | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $322,000 | -8.3% | 5,064 | 0.0% | 0.48% | 0.0% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $320,000 | -0.6% | 11,981 | 0.0% | 0.47% | +8.5% | |
| IQV | IQVIA HLDGS INC | $319,000 | +11.5% | 1,985 | 0.0% | 0.47% | +21.6% | |
| CRL | CHARLES RIV LABS INTL INC | $300,000 | -2.3% | 2,112 | 0.0% | 0.44% | +6.7% | |
| GRFS | Buy | GRIFOLS S Asp adr rep b nvt | $278,000 | +5.7% | 13,196 | +0.9% | 0.41% | +15.4% |
| GILD | Buy | GILEAD SCIENCES INC | $276,000 | +16.0% | 4,082 | +11.3% | 0.41% | +26.3% |
| BIIB | New | BIOGEN INC | $263,000 | – | 1,123 | +100.0% | 0.39% | – |
| AMGN | Buy | AMGEN INC | $257,000 | +8.9% | 1,397 | +12.5% | 0.38% | +18.8% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $254,000 | +2.8% | 3,012 | +7.3% | 0.38% | +12.2% |
| EXEL | EXELIXIS INC | $244,000 | -10.3% | 11,440 | 0.0% | 0.36% | -2.2% | |
| LGND | Buy | LIGAND PHARMACEUTICALS INC | $241,000 | +10.0% | 2,111 | +21.0% | 0.36% | +20.2% |
| AGIO | AGIOS PHARMACEUTICALS INC | $240,000 | -25.9% | 4,806 | 0.0% | 0.36% | -19.1% | |
| FGEN | Buy | FIBROGEN INC | $221,000 | -15.6% | 4,883 | +1.2% | 0.33% | -7.9% |
| REPH | RECRO PHARMA INC | $115,000 | +71.6% | 11,353 | 0.0% | 0.17% | +86.8% | |
| XON | Exit | INTREXON CORP | $0 | – | -32,284 | -100.0% | -0.23% | – |
| ACIU | Exit | AC IMMUNE SA | $0 | – | -39,801 | -100.0% | -0.27% | – |
| SURF | Exit | SURFACE ONCOLOGY INC | $0 | – | -53,063 | -100.0% | -0.34% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -2,199 | -100.0% | -0.35% | – |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -25,284 | -100.0% | -0.37% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -7,722 | -100.0% | -0.38% | – |
| SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -33,529 | -100.0% | -0.43% | – |
| XNCR | Exit | XENCOR INC | $0 | – | -10,935 | -100.0% | -0.46% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -9,716 | -100.0% | -0.51% | – |
| RUBY | Exit | RUBIUS THERAPEUTICS INC | $0 | – | -21,610 | -100.0% | -0.53% | – |
| SUPN | Exit | SUPERNUS PHARMACEUTICALS INC | $0 | – | -11,648 | -100.0% | -0.55% | – |
| CLLS | Exit | CELLECTIS S Asponsored ads | $0 | – | -22,309 | -100.0% | -0.55% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -8,832 | -100.0% | -0.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| METTLER-TOLEDO INTL CMN | 20 | Q3 2019 | 4.7% |
| ALNYLAM PHARMACEUTICALS, INC. CMN | 20 | Q3 2019 | 5.0% |
| VERTEX PHARMACEUTICALS INC CMN | 20 | Q3 2019 | 4.0% |
| ILLUMINA, INC. CMN | 20 | Q3 2019 | 4.4% |
| SEATTLE GENETICS, INC. CMN | 20 | Q3 2019 | 4.0% |
| ALEXION PHARMACEUTICALS INC CMN | 20 | Q3 2019 | 4.3% |
| INCYTE CORPORATION CMN | 20 | Q3 2019 | 4.4% |
| NEKTAR THERAPEUTICS CMN | 20 | Q3 2019 | 4.9% |
| REGENERON PHARMACEUTICALS | 20 | Q3 2019 | 3.8% |
| CELGENE CORPORATION CMN | 20 | Q3 2019 | 3.8% |
View Opus Point Partners Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-17 |
| 13F-HR | 2017-11-14 |
View Opus Point Partners Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.